Press Releases

Press Releases

Sep 14, 2021
Twist Bioscience Continues Commitment to Deliver Synthetic RNA Controls, now to Fight Delta Plus Variants of COVID-19
Sep 13, 2021
Twist Bioscience Collaborates with Adicet Bio to Accelerate Discovery of Gamma Delta T Cell Cancer Therapeutics
Sep 09, 2021
Boehringer Ingelheim and Twist Bioscience Enter Therapeutic Antibody Discovery Collaboration
Sep 08, 2021
Twist Bioscience to Present at Baird 2021 Global Healthcare Conference
Aug 10, 2021
Twist Bioscience to Present at UBS Genomics 2.0 and Medtech Innovations Summit
Aug 06, 2021
Twist Bioscience Reports Third Quarter Fiscal 2021 Financial Results
Aug 06, 2021
Twist Bioscience Appoints Drug Discovery Leader Melissa Starovasnik, Ph.D., to Board of Directors
Jul 26, 2021
Twist Bioscience Incorporates MOLCURE AI Technology to Augment Therapeutic Antibody Discovery
Jul 22, 2021
Twist Bioscience Now Shipping Synthetic RNA Positive Controls for Delta (B.1.617.2) SARS-CoV-2 Variant for Development of Accurate Diagnostic Tests
Jul 21, 2021
Twist Bioscience to Report Fiscal 2021 Third Quarter Financial Results on Friday, August 6, 2021